Occupational exposure to cytotoxic drugs in two UK oncology wards.
OBJECTIVE
To investigate the potential exposure to cytotoxic drugs of staff on two oncology wards in a large district, UK hospital under normal working conditions.


METHODS
Cytotoxic drug exposure was monitored in urine samples, surface wipes, and on disposable gloves by using a number of commonly used marker drugs, namely cyclophosphamide, ifosfamide, methotrexate, and the platino coordinated drugs. Questionnaire data on their work practices, potential exposure, use of protective personal equipment, and relevant training were collected from nursing, domestic, and clerical staff on two oncology wards.


RESULTS
The majority of staff were female with a mean age of 31 years. Roughly half of the staff studied were specifically trained nurses with an average of 3.5 years experience of administering cytotoxic drugs. No cytotoxic drug preparation or reconstitution was carried out on the wards. Disposable gloves, plastic armlets and aprons, but not eye protection, were invariably worn where there was potential exposure to cytotoxics. No cytotoxic drug was detected in any of the staff's urine samples. Isolated disposable latex gloves from nurses administering drugs showed some contamination, as did some surfaces within the wards' sluice rooms, but not in the ward areas where the drugs were stored and checked prior to administration.


CONCLUSIONS
The risk management strategies in place, including use of personal protective equipment, staff training, and other organisational measures, have ensured that internal exposure is lower than the detection limits for the current biological monitoring methods. Levels of contamination appear significantly lower than earlier, non-UK published studies where different risk management strategies were in place and, in particular, ward staff may have been involved in some degree of cytotoxic drug reconstitution.
Ziegler
E
E
Southampton University Hospital Trust, Southampton, UK.
Mason
Howard J
HJ
Baxter
P J
PJ
D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000032:analysis / Q000652:urine; D004739:England; D004784:Environmental Monitoring / Q000379:methods; D004866:Equipment Contamination; D005260:Female; D017575:Gloves, Protective; D006767:Hospitals, District; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D009741:Nursing Staff, Hospital; D016273:Occupational Exposure / Q000032:analysis*; D016522:Oncology Service, Hospital
D000970:Antineoplastic Agents